No class action for Vioxx refunds to consumers, US court says
20 March 2009
Nancy Faigen
Please Login to read the full article.
20 March 2009
Nancy Faigen
A New Jersey state court has denied plaintiffs' request to certify a class of consumers who sought to recoup out-of-pocket expenses for their use of Merck & Co's withdrawn painkiller Vioxx (rofecoxib).
The consumers were not alleging any personal injury – rather they were...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Supreme Court to weigh generic drug liability, patent burden-of-proof standards
- J&J to pay $158M to settle Texas Medicaid fraud case
- Merck & Co wins another US Fosamax bellwether case
- US Capitol Capsule: NIH confesses error on unapproved drugs, but sets no deadline for changes
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
